[EN] NOVEL THERAPY FOR PROSTATE CARCINOMA<br/>[FR] NOUVELLE THÉRAPIE POUR LE CARCINOME DE LA PROSTATE
申请人:PELLFICURE PHARMACEUTICALS INC
公开号:WO2014158875A1
公开(公告)日:2014-10-02
Disclosed herein are methods of inhibiting or delaying the growth of androgen-dependent prostate cancer, and/or inhibiting or delaying the onset of castration-resistant prostate cancer (CRPC) by administering naphthoquinone analogs, such as plumbagin, and specified hormone therapy agents, including selective inhibitors of 17,20-lyase activity of CYP 17.
Dean; Nierenstein, Journal of the Chemical Society, 1916, vol. 109, p. 595